Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px
Document › Details

Innogenetics N.V.. (9/24/10). "Press Release: Fujirebio Completed the Acquisition of Innogenetics". Tokyo.

Organisations Organisation Innogenetics N.V.
  Today Fujirebio Europe N.V.
  Group Miraca (Group)
  Organisation 2 Fujirebio Inc. (JP)
  Today Miraca Holdings Inc.
  Group Miraca (Group)
Product Product diagnostics (medical/biological)
Index terms Index term Abbott–Miraca: investment, 201007–201009 acquisition of Innogenetics by Fujirebio from Abbott
  Index term 2 Solvay–Abbott: investment, 200909–201002 acquisition Solvay Pharmaceuticals €4.8b with €4.5b in cash + €300m milestones + assumption liabilities €400m
     


Fujirebio, a Miraca Holdings group company, has completed the acquisition of all of the issued and outstanding shares of Innogenetics NV. The acquisition was consummated in accordance with the terms and conditions of the definitive agreement that had been referred to in Fujirebio's previous release ("Fujirebio to acquire Innogenetics from Abbott") dated July 20, 2010.


About Innogenetics

Innogenetics NV is an international biotechnological company that develops and markets diagnostic products to improve therapy management and patient health.

Innogenetics develops and markets a wide range of diagnostic assays with a focus on molecular Diagnostics and multiparameter testing. Its products are sold in over 90 countries through its 6 subsidiaries and a large number of distributors.


Forward looking statement

This press release contains forward-looking statements that involve risks and uncertainties, including but not limited to projections of future revenues, operating income, and other risks. Prospective investors should be aware that these statements are estimates, reflecting only the judgments and projections of Innogenetics' management, and no undue reliance should be placed on such forward-looking statements.

   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px

More documents for Miraca (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px




» top